Floyd Stephen Laroux, Jr

Title: Floyd Stephen Laroux, Jr.: Innovator in Gene Silencing Technologies

Introduction

Floyd Stephen Laroux, Jr. is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of gene silencing. With a total of 2 patents, his work has the potential to impact various medical applications.

Latest Patents

Laroux's latest patents focus on bacteria-mediated gene silencing. These patents describe methods for delivering small interfering RNAs (siRNAs) to eukaryotic cells using a bacterium or BTP. The methods also include regulating gene expression in eukaryotic cells through RNA interference, as well as treating viral diseases and disorders. The bacterium or BTP can contain one or more siRNAs or DNA molecules encoding these siRNAs. Additionally, vectors are described for use with the bacteria to facilitate RNA interference in eukaryotic cells.

Career Highlights

Throughout his career, Laroux has worked with several prominent companies in the biotechnology sector. Notable among these are Marina Biotech, Inc. and Cequent Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in gene therapy and biotechnology innovations.

Collaborations

Laroux has collaborated with several professionals in his field, including Moreshwar Bhanudas Vaze and Johannes Fruehauf. These collaborations have likely enriched his research and development efforts.

Conclusion

Floyd Stephen Laroux, Jr. is a distinguished inventor whose work in gene silencing technologies holds promise for advancing medical treatments. His contributions to biotechnology continue to influence the field significantly.